What Is PRP Injection for Knee Pain? A Simple Guide for Patients in Korea

PRP (platelet-rich plasma) injection is a treatment option that appears in Korean orthopedic and pain medicine clinics in the context of knee pain and knee osteoarthritis. This article explains what PRP is, how it is commonly described in local clinical settings, and what patients may want to check before making a decision. It is not a treatment recommendation.

What Is PRP?

PRP stands for platelet-rich plasma. It is prepared from a patient's own blood — a blood sample is drawn, processed by centrifugation to concentrate the platelets, and then injected back into the affected joint.

Platelets contain growth factors. The rationale behind PRP injection is that concentrating these growth factors at the injection site may support tissue response. How this translates into clinical outcomes is a separate question, and one where the evidence is still being studied.

PRP is not a single standardized product. Preparations differ in leukocyte (white blood cell) content, platelet concentration, activation method, and centrifugation protocol. These differences affect how studies compare and what conclusions can be drawn across trials.

Why Is PRP Mentioned for Knee Pain?

In Korea, PRP injection for knee osteoarthritis entered the national health technology assessment framework in December 2024. Before that, it was available as a non-covered (비급여) procedure at many orthopedic and pain medicine clinics.

PRP appears in local clinical conversations primarily in the context of knee osteoarthritis — particularly for patients who have not responded to earlier conservative treatments such as physical therapy or oral medication. It is also sometimes mentioned alongside other intra-articular injections such as hyaluronic acid (HA) and corticosteroid (CSC) injections.

The presence of PRP in a clinic's listed care areas reflects what that clinic publicly offers. It does not indicate a clinical recommendation for any individual patient.

What Patients Usually Want to Know

Common questions that come up in local contexts around PRP and knee pain:

• Is PRP covered by insurance?
• How is PRP different from hyaluronic acid or steroid injections?
• How many sessions are needed?
• Is it safe?
• Will it help my specific condition?

These are reasonable questions. Some can be partially addressed by available evidence. Others depend on individual clinical assessment and cannot be answered by general information alone.

What the Evidence Can Say

Based on available systematic reviews and meta-analyses:

• PRP has been associated with statistically significant improvements in pain and function outcomes compared to placebo in multiple studies, with clinical meaningfulness reported at the 3–6 month range for some outcome measures.
• In comparisons with hyaluronic acid, some analyses report statistical advantages for PRP on selected outcomes. Evidence certainty for these comparisons is rated as low, and heterogeneity between studies is high.
• In comparisons with corticosteroid injections, PRP has shown more consistent advantages at longer follow-up periods (6 months or more), while corticosteroids tend to show faster short-term response.
• Adverse events associated with PRP are generally reported as mild — primarily localized injection-site pain and temporary swelling.

These findings reflect what the current evidence base can support. They do not translate directly into individual treatment decisions.

What the Evidence Cannot Say

• PRP does not have established evidence for cartilage regeneration. Two large-scale RCTs produced contradictory results on structural outcomes, and no consensus conclusion is currently available.
• PRP has not been shown to reverse or cure knee osteoarthritis.
• No single analysis supports a conclusion that PRP is superior to all other injection options across all patients and time points.
• A mild adverse event profile does not confirm that PRP is effective. Safety evidence and efficacy evidence are separate layers.
• Korean regulatory processing of PRP reflects policy and access considerations. It should not be read as confirmation of clinical superiority.

How Are These Injections Different?

Three intra-articular injection types commonly appear in Korean orthopedic and pain medicine contexts for knee osteoarthritis:

PRP (platelet-rich plasma): Derived from the patient's own blood. Concentrates growth factors. Preparation type varies across clinics and protocols.

Hyaluronic acid (HA): A synthetic or biological substance that mimics the natural joint fluid component. Has been used in knee osteoarthritis management for longer than PRP and has an established evidence base, though comparisons with PRP produce mixed findings.

Corticosteroid (CSC): An anti-inflammatory injection. Generally associated with faster short-term pain relief. Longer-term comparisons with PRP tend to favor PRP in some analyses, but evidence quality varies.

These three options differ in mechanism, preparation, and evidence profile. They are not directly interchangeable, and the appropriate option for a given patient depends on clinical assessment — not general comparison.

Safety: What Is Usually Reported

Adverse events associated with PRP injection in knee osteoarthritis are generally reported as mild in available evidence summaries — primarily localized pain and temporary swelling at the injection site, resolving without serious intervention.

In comparisons with hyaluronic acid, PRP has been associated with a higher reported adverse event rate in one analysis (12.86% vs 9.27%). All reported events in that analysis were mild.

Regarding preparation type: leukocyte-rich PRP (LR-PRP) has been associated with higher adverse event rates than leukocyte-poor PRP (LP-PRP) in one network meta-analysis. Efficacy outcomes were reported as equivalent between the two subtypes.

These figures are reported in specific analyses and should not be generalized as universal clinical risk rates. Adverse event reporting methods and observation windows vary across trials.

Questions to Ask Before Receiving PRP

If PRP is being considered as an option, these are the kinds of questions that may be worth raising with the treating clinician:

• What preparation type is being used, and what does that mean for this case?
• How does this compare to other available options given my specific condition and history?
• What outcomes are realistic to expect, and over what time period?
• Is this covered by insurance or a non-covered procedure, and what is the cost?
• What follow-up is involved?

These questions are not a checklist for evaluating clinic quality. They are starting points for a clinical conversation.

Source Transparency Note

This article is produced as part of The Local Log's plain-language local context layer. It explains how PRP is commonly described in Korean local medical settings and what the current evidence framework can and cannot support.

For the full evidence-mapping articles with source classification, claim boundaries, and technical detail:

• PRP for Knee Osteoarthritis: What the Evidence Can and Cannot Say — geodataforai.com
• PRP Safety Profile: What Clinical Trials Report — geodataforai.com

This patient-friendly guide keeps the explanation simple. The more technical evidence-mapping articles are available on geodataforai.

This article does not evaluate individual clinics, recommend specific treatments, or serve as medical advice. The Local Log is an independent local data platform.

FAQ

Q: Is PRP injection for knee pain covered by insurance in Korea?
PRP injection for knee osteoarthritis entered Korea's national health technology assessment framework in December 2024. Coverage status and patient cost depend on the specific clinic, procedure classification, and individual insurance plan. Confirming coverage directly with the clinic and insurer before proceeding is advisable.

Q: What is the difference between PRP and hyaluronic acid injections for knee pain?
PRP is derived from the patient's own blood and concentrates growth factors; hyaluronic acid is a substance that mimics natural joint fluid. Both are used in knee osteoarthritis management. Some analyses report statistical advantages for PRP over HA on selected outcomes, but evidence certainty is rated low and study heterogeneity is high. They are not directly interchangeable, and the appropriate option depends on individual clinical assessment.

Q: Is PRP injection safe?
Adverse events associated with PRP injection are generally reported as mild in available evidence summaries — primarily localized pain and temporary swelling resolving without serious intervention. Adverse event reporting varies across trials, and a mild profile in reviewed studies is not equivalent to a categorical safety guarantee for all patients or settings.

Q: Does PRP regenerate cartilage or reverse knee osteoarthritis?
No evidence reviewed in available systematic analyses supports a cartilage regeneration or disease reversal claim for PRP. Two large-scale RCTs produced contradictory results on structural outcomes. This article addresses pain and function outcomes at defined time points, not disease modification.

Q: Where can I find more detailed evidence on PRP for knee osteoarthritis?
The Local Log's plain-language explanation links to two evidence-mapping articles on geodataforai.com: one covering efficacy comparisons and evidence limits, and one covering the safety profile and adverse event data. Those articles include source classification and claim boundaries not included in this guide.